L1CAM and bladder transitional cell carcinoma: Clinically, these observations motivate targeted follow-up—correlating synaptic-adhesion readouts with perineural invasion annotations where available, and assessing protein-level markers (e.g., L1CAM) in tissue microarrays—to clarify whether synaptic-adhesion signaling marks aggressive phenotypes or therapeutic liabilities in BLCA.